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Abstract
Trace elements can play an important role in maternal health and fetal development, and 
deficiencies in some essential minerals including zinc and copper have been correlated in some 
individuals to the development of birth defects and adverse health outcomes later in life. The exact 
etiology of conditions like preeclampsia and the effects of fetal exposure to toxic metals has not 
been determined, making the assessment of trace element levels crucial to the elucidation of the 
causes of conditions like preeclampsia. Previous studies analyzing serum and placenta tissue have 
produced conflicting findings, suggesting the need for a robust, validated sample preparation and 
analysis method for the determination of trace elements in placenta. In this report, an acid 
digestion method and analysis by ICP-MS for a broad metallomics/mineralomics panel of trace 
elements is developed and validated over three experimental days for inter- and intraday precision 
and accuracy, linear range, matrix impact, and dilution verification. Spike recovery experiments 
were performed for the essential elements chromium (Cr), iron (Fe), cobalt (Co), nickel (Ni), 
copper (Cu), and zinc (Zn), and the toxic elements arsenic (As), cadmium (Cd), and lead (Pb) at 
levels equal to and in excess of native concentrations in control placenta tissue. The validated 
method will be essential for the development of scientific studies of maternal health and toxic 
metal exposure effects in childhood.
Introduction
Trace elements play a role in a variety of biological processes in humans ranging from the 
transport of small molecules to the catalysis of redox reactions in cells.[1] While dietary 
intake of essential minerals is a requirement to sustain these biological processes, a variety 
of factors can result in improper absorption or utilization of the metals. This deficiency can 
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result in adverse health effects to the individual, and these health effects can become doubly 
threatening when the individual is pregnant. In the same way, an exposure to an excess of an 
essential mineral or to a toxic metal can result in illnesses resulting from toxicity. For 
example, an excess of iron such as in hemochromatosis or excessive iron supplementation 
can result in increased cellular oxidative damage.[2]
Previous studies of health outcomes such as preeclampsia, low birth weight, intra-uterine 
growth restriction (IUGR), and childhood neurological effects in the fetus have focused on 
the analysis of serum and plasma from the mother, but the placenta has a more direct role in 
the development and sustenance of the fetus and can be viewed as a biological indicator of 
exposure of the fetus to toxic compounds before birth. Placenta tissue has previously been 
used as a matrix for studying fetal exposure to contaminants including toxic metals and for 
relation to the development of diseases.[3–5] The results of these investigations have 
provided conflicting findings regarding correlations between exposure and toxic metal 
concentrations in placenta tissue.
One potential explanation for the inconsistent findings of studies of trace metals in placenta 
may arise from the analytical method used to monitor the elemental concentrations. 
Inconsistent analytical methods between studies can result in variability in elemental 
concentrations, especially for trace elements that approach the limits of detection and 
quantification for the methods. This is especially true for the analysis of organ tissue, which 
can exhibit uneven spatial distribution, making the exact sampling and preparation methods 
crucial to the outcome of the study. In order to draw sound scientific conclusions from 
bioanalysis research projects, it is important to have a robust validated analytical method.
[6,7] While some methods may focus on the analysis of a single analyte to investigate causal 
relationships between the analyte and the health outcome, biological systems are often more 
complicated and require multifactorial analyses to elucidate the complex interrelationships 
of a broad panel of analytes, or “-omics” type approaches. “Metallomics” is an 
encompassing term for the study of metals and their function in cells that has seen increased 
visibility and attention in recent years.[8–11] An additional subset of metallomics has 
recently been described that focuses on the essential nutritional metals or minerals that is 
referred to as “mineralomics.” [12,13] It is especially important to carefully validate broad 
panel “omics” methods to ensure that accurate results are achieved for all elements included 
in the analytical method.
The purpose of this study was to develop and validate an analytical method for a suite of 
toxic and essential metals in placenta tissue to support studies of the relationships between 
trace elements and health outcomes in pregnancy. The primary analyte of interest was zinc 
(Zn), but the method was also validated for the essential elements chromium (Cr), iron (Fe), 
cobalt (Co), nickel (Ni), and copper (Cu), and the toxic elements arsenic (As), cadmium 
(Cd), and lead (Pb) at varying concentrations. The validation was performed by 
bioanalytical method guidelines to demonstrate interday (same day) and intraday (different 
day) accuracy and precision for these elements in the human placental matrix. The method 
was shown to be valid for the elements of interest at levels comparable to or above the 
native concentrations in the tissues.
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Methods and Materials
Samples and Materials
Two whole human placenta samples were purchased from Bioreclamation IVT (Baltimore, 
MD) and were stored at a nominal temperature of −80 °C until time of use. Samples were 
collected from healthy volunteers and were used as received for preparation. Sample 
collection procedures followed the Helsinki Declaration guidelines regarding informed 
consent of human volunteers. Samples were fortified and calibration standards were 
prepared with the elements of interest by spiking with stock standards that were prepared 
with National Institute of Standards and Technology (NIST)-traceable standards of As, Cd, 
Co, Cr, Cu, Ni, Pb (all 10 μg/mL), Fe, and Zn (both 1000 μg/mL) purchased from High 
Purity Standards (Charleston, SC). Prepared samples and calibration standards were spiked 
with NIST-traceable Bi, In, Pr, and Y standards (10 μg/mL) as internal standards that were 
also purchased from High Purity Standards. Samples were prepared with concentrated, 70% 
(v/v) nitric acid (HNO3, Optima purity, Thermo-Fisher) and high purity 30% (v/v) hydrogen 
peroxide (H2O2, Ultrex purity, non-stabilized, Thermo-Fisher Scientific, Waltham, MA). 
Approximately 18 MΩ cm−1 water was used in all sample preparation and analysis steps.
Validation guidelines
Digested samples were prepared from a homogenized mixture of two whole human placenta 
and were used to prepare multiple replicates of samples that were spiked at seven 
concentration levels representing a range of concentrations relative to native levels (Table 
S1, Supplemental Information). Samples were prepared in triplicate at all concentration 
levels and on three separate, non-consecutive analytical days, and multiple replicates (n = 6) 
were prepared at the two lowest nominal concentration levels to challenge detection and 
quantitation limits. The preparation of samples in at least triplicate was performed to assess 
interday (same day) accuracy and precision, and the repetition of analyses on at least three 
non-consecutive analytical days was intended to assess intraday (different day) accuracy and 
precision. The limit of detection (LOD), and lower limit of quantification (LLOQ), and 
selectivity were assessed by analysis of six replicates of the lowest concentration spike 
levels on the first analytical day. In addition, on the first analytical day, a series of matrix 
standards were prepared for comparison to solvent standards in order to assess matrix effects 
on analyte signal. On the second analytical day, three replicate samples were spiked and 
prepared at nominal concentrations exceeding analyte linear ranges to perform a dilution 
verification check.
Instrumentation
All samples were prepared in a Class 100 clean hood to prevent contamination by 
atmospheric particulates. After digestion, the samples were analyzed for trace minerals using 
the Thermo (Bremen, Germany) X-Series I inductively-coupled plasma mass spectrometer 
(ICP-MS) equipped with a concentric glass nebulizer, collision cell technology (CCT) and 
Peltier-cooled glass spray chamber. Digestion of samples was performed using a DigiPrep 
graphite block digestion unit (SCP Science, Quebec) equipped for 15 mL digestion vessels.
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Digestion method
A scheme of the sample preparation method is shown in Figure 1 and details are provided in 
Table S2 (Supplemental Information). In order to promote an even distribution of tissue and 
promote optimal acid digestion of samples throughout, tissue samples were massed and 
homogenized by mixture with 2 times the sample weight of concentrated Optima-purity 
nitric acid in a heated circulating water bath and stirring until smooth. Nominal 0.500 mL 
homogenate aliquots were transferred to acid-washed 15-mL digestion vessels and directly 
spiked with elemental intermediate stock solutions at concentrations described in Table S1. 
After spiking, 0.500 mL of HNO3 and 0.100 mL of H2O2 were added to each vessel and the 
cap was placed loosely on the vessel. All vessels were placed in the graphite block digestion 
unit at 100 °C for 60 minutes and the digestion vessels were removed to allow to cool to 
room temperature. Samples were spiked with internal standard stock solution to a final 
concentration of 2 ng/mL to provide a measure of matrix effects on analyte ionization in the 
plasma and provide an indicator of instrument performance throughout the analysis, and the 
solutions were diluted to a final volume of 10 mL with DI water.
Sample analysis
Sample analysis was performed by quadrupole ICP-MS (Table 1). Calibration ranges were 
prepared to contain both the native concentrations of the trace elements and the spiked levels 
of all elements. All elements were analyzed in kinetic energy discrimination (KED) mode 
with 10% H2/He collision cell gas to minimize polyatomic interferences. System suitability 
was monitored throughout the analysis by measurement of multiple matrix QC samples over 
a range of concentrations. Blank samples were measurement immediately after calibration to 
confirm a lack of analyte carryover. For the calibration, standards were accepted as passing 
if their back-calculated concentration was found to be within ±15% of the nominal 
concentration (±20% of the nominal concentration for the lowest concentration standard). At 
least 8 calibration standards were required to pass in order to accept the calibration curve as 
valid for the analytical day.
Calculations
Analytical recovery of spiked samples was calculated using Eq. 1 for bias (relative error):
(1)
Where Cmeas represents the measured concentration of each element, CMxB represents the 
average measured concentration of the element in five replicates of matrix blank samples, 
and Cnom represents the nominal concentration for the element at that concentration level. 
Precision was calculated as the relative standard deviation (RSD) of repeated analyses of the 
same concentration level, shown in Eq. 2:
(2)
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Where σn represents the standard deviation of all measurements.
Matrix impact was calculated for each element as the ratio of the slope of the calibration 
curve obtained from matrix standards (mMx) to the slope of the calibration curve obtained 
from solvent standards (mSolv), Eq. 3:
(3)
Results
Precision and accuracy
Results for intraday precision and accuracy for all three validation days are presented in 
Tables 2 and 3. For analytes (Table 2 and Table 3), precision and accuracy were required to 
be ≤20% and within ±20%, respectively. These pre-defined acceptance criteria were 
achieved for all analytes and concentration levels on all three validation days, indicating that 
the validated analytical method was robust and fit for purpose.
Analytical limits
Analytical measurement limits for the analyte suite are presented in Table 4. The lower limit 
of quantitation (LLOQ) was conservatively defined as the lowest nominal matrix QC level 
meeting the above described a priori defined precision and accuracy acceptance criteria on 
each of three validation days. To further challenge the analytical method, six replicates at 
the lowest two nominal concentration levels were prepared on the first validation day (Table 
S1). The limit of detection (LOD) for each analyte was then calculated as three times the 
standard deviation of the determined concentration at the LLOQ level on the first validation 
day. A total of six replicates were used to establish these figures of merit for all elements 
except for As and Cr, which had three replicates because it was necessary to shorten the 
linear range to meet precision and accuracy acceptance criteria. The upper limit of 
quantitation (ULOQ) for each analyte was defined as the highest level matrix standard 
included in the linear regression on all validation days. The reported preparation and 
analytical method has provided validated analytical ranges between one and two orders of 
magnitude depending on the identity and endogenous levels of each element.
Dilution verification and matrix impact
Precision and accuracy data from the dilution verification matrix samples (Table S1) are 
presented in Table 5. Precision (%RSD) and accuracy (%RE) were required to be ≤ 20% and 
within ±20%, respectively, for all other analytes. These pre-defined acceptance criteria were 
easily achieved, indicating the feasibility of diluting samples to have determined 
concentrations that fall within validated linear ranges. The pre-defined acceptance criterion 
was a slope ratio within ±20% for all analytes in the suite. This criterion was achieved on 
the first validation day indicating that the overall matrix impact was not significant, so all 
precision and accuracy calculations were conducted using solvent curves.
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Discussion
Digestion method
In ICP-MS methods and in bioanalytical methods, the sample preparation technique is of the 
utmost importance to ensure that consistent, reliable analytical results are obtained. It is 
necessary to ensure complete solubilization of the elements of interest uniformly throughout 
the sample solution and that minimal particulate matter remains in the solution, which could 
potentially clog the nebulizer of the instrument.
The first step of the sample preparation technique, homogenization of the tissue prior to 
digestion, has been successfully applied to previous method validation efforts for other 
analytes and tissues.[14] Homogenization assists in the degradation of the tissue in solution 
by providing more exposed surface area for acid digestion to occur. The process also helps 
to provide a uniform distribution of the element throughout the solution, as opposed to 
previous studies, which cut small masses of tissue from the whole organ.[4,5,15] This 
sample preparation method may not account for the possibility of the localization of 
elements within the mass of tissue, potentially resulting in artificially high or low results for 
the elements of interest.
Another difference in the method applied here is that digestion of the tissue is occurring 
through the use of a graphite digestion unit rather than microwave digestion. While 
microwave assisted digestion is appropriate for some types of samples, graphite heating unit 
digestion is a less-expensive, gentler digestion technique that is fit for the intended purpose 
described in this validation[16] The application of cost-effective, graphite heating digestion 
units can result in a less violent digestion than microwave digestion and a lower probability 
of sample loss due to frothing or bursting of digestion vessels. Further, the homogenization 
step serves to perform a predigestion of the sample, breaking down much of the organic 
matter before the addition of hydrogen peroxide, which produces more frothing than nitric 
acid alone. Previous studies have used cryogenic grinding of biological samples to 
homogenize the sample prior to microwave digestion with some success, but this method of 
homogenization requires the purchase of specialized equipment, which was not required for 
this reported method.[17]
Method figures of merit
The LLOQ, LLOD, and ULOQ for each analyte, presented as μg element/g tissue, were 
robustly established and confirmed over three validation days. One previous study reported 
limits of detection for Cd, As, and Pb of 0.007 ng/g, 0.041 ng/g, and 0.01 ng/g, respectively, 
although the method used to determine the limits was not described.[15] Another 
investigation reported the LOD for the elements of interest as Fe = 0.0016 ng/g, Co = 0.002 
ng/g, Cu = 0.0002 ng/g, Zn = 0.0058 ng/g, As = 0.02 ng/g, Cd = 0.001 ng/g, and Pb = 0.003 
ng/g.[5] However, these values were calculated as 3 times the standard deviation of blank 
samples, but an LLOQ as defined above may be a more realistic estimate of values that can 
be consistently achieved due to the requirement of meeting predefined acceptance criteria 
for both accuracy and precision. Another study reported limits of detection of 0.4 ng/mL for 
Pb, 0.08 ng/mL for Cd, 4 ng/mL for Zn, and 1 ng/mL for Cu. These values appear to be 
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more consistent with those obtained in the current study. However, it is unclear whether any 
of these studies take into account dilution of the samples as a result of the sample 
preparation method, a phenomenon that is taken into account with the results reported here. 
Further, the values determined in this validation are supported by a more robust method of 
determination of the limits owing to the use of multiple measurements of quantifiable 
samples. This method of determination is also the explanation of the relatively high limits 
determined for Fe and Zn, elements that suffer from appreciable polyatomic interferences 
(Table S3) and lower sensitivity in KED mode. However, it is unlikely that samples of this 
type will ever exhibit concentrations that challenge the limit of detection owing to the high 
native concentrations of the elements in tissues.
Broad panel analyses
Broad panel analyses such as the one described here can have a significant impact in 
elucidating the causal relationships that can produce harmful health outcomes. In the study 
of complex conditions such as preeclampsia where the exact etiological factors that result in 
their development are uncharacterized, a holistic approach to the complex interrelationships 
between different compounds, in this case minerals, can be informative. The approach 
described here can also provide a “shotgun” approach to toxicological studies, producing a 
maximum amount of information to determine correlations between health outcomes later in 
life and early life exposures to toxic metals or trace mineral deficiencies.
Another advantage to the “omics” approach described here is that the method described uses 
a minimal amount of sample for each measurement. “Omics” approaches often make use of 
minimal amounts of tissue or biological fluid in order to maximize the number of analyses 
that can be performed and minimize the invasiveness of sample collection, allowing the 
collection of a vast amount of data from a small amount of tissue. This approach can be 
particularly effective for performing research on samples that are stored in biological sample 
repositories, where the sample mass may be limited.
However, the use of the broad panel analysis method by ICP-MS can potentially suffer from 
challenges to some of the analytes of interest. Polyatomic interferences (Table S3) can result 
in difficulties in the consistent determination of the concentration of analytes without the use 
of corrective measures. In this analysis, all elements were analyzed in kinetic energy 
discrimination mode (KED mode, also known as collision cell mode or CCT mode) with 
H2/He gas to minimize the presence of polyatomic interferences, which could pose 
significant analytical challenges for a number of the elements in biological matrices, shown 
in Table S3.[18] Analysis in KED mode also results in decreased sensitivity for all elements 
compared to standard mode analysis. This issue is a particular concern for the analysis of Cr 
(ArC and CaC polyatomic interferences) and Co, where the native levels of the metals are 
very low, to the point of approaching the limits of detection. The exogenous toxic metal 
arsenic also suffers from a polyatomic interference in high salt solutions due to the 
formation of the ArCl species in the plasma, necessitating its analysis in KED mode.[19] It 
is possible that the use of higher resolution analysis modes, such as by sector-field ICP-MS 
(SF-ICP-MS) could provide higher sensitivity and lower limits of detection for challenging 
elements.[20]
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In some cases, it may also be possible to analyze an alternate isotope that does not suffer 
from the same interferences or has interferences that contain lesser abundant isotopes of 
their own elements. This can allow the analyst to obtain higher sensitivity for the element of 
interest (if the isotope is sufficiently abundant that the signal is greater than that obtained 
with the primary isotope in KED mode). Conversely, lead and cadmium do not suffer from 
any commonly-observed polyatomic interferences in ICP-MS, making it possible to quantify 
the elements without the use of KED mode, such as in a multimode analytical run, allowing 
lower limits of detection and quantification for those analytes. However, this could in some 
cases present challenges resulting from the need to consume increased volumes of the 
sample as the instrument would perform two sets of scans, one in standard mode and another 
in KED mode. It is also possible to use interference correction equations to account for the 
formation of polyatomic interferences.[21] However, this practice is less accurate than other 
forms of interference exclusion, as it assumes constant rates of formation of polyatomic 
interferences, and requires thorough and repeated characterization of the correction factors 
necessary to accurately calculate the analyte counts throughout the analysis. This approach 
may be better suited to laboratories that do not have instruments equipped with collision 
cells, but can also over- or under-compensate depending on the levels of analyte and 
interference.
Finally, it is important to note that the methods described here have only definitively been 
shown to produce accurate analytical results for the elements reported here. The analysis of 
other elements, such as the alkali metals, has not been definitively demonstrated and will 
require additional work to verify the appropriateness of these digestion and analysis methods 
prior to their use.
Applications
The analytical approach validated in this study was primarily developed to address 
correlations between the occurrence of preeclampsia and zinc levels in the placenta. 
However, the broad panel analysis validated here can be applied to a variety of health equity 
issues, some of which have been described in previous reports citing correlations between 
trace element concentrations and health outcomes. The studies reported thus far have 
touched on the potential roles for specific analytes in the prenatal or early childhood 
development of illnesses, but a detailed link to prenatal exposure and mineral nutrition status 
has not been explored and the method described here may be able to provide a more detailed 
link between these factors.
Preeclampsia is a serious multisystemic medical condition in pregnant women that is 
generally observed after 20 weeks of gestation and is characterized by new-onset elevated 
blood pressure and proteinuria, among a variety of other symptoms.[22,23] Advanced cases 
of preeclampsia can result in serious medical complications in the mother including stroke 
and heart disorders, as well as fetal outcomes including IUGR.[24] The development of the 
placenta has been found to be linked to some of the maternal symptoms of preeclampsia.[22] 
The condition is currently one of the leading causes of mother and infant morbidity and 
mortality, and is especially prevalent in the developing world, where malnutrition leads to 
decreased dietary intake of many essential nutrients.[25,26] The occurrence of preeclampsia 
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has also been linked to the development of noncommunicable diseases later in life.[27] The 
only effective cure for preeclampsia is delivery or abortion, making early manifestation of 
the disease a challenge to maintain maternal health until the fetus can mature sufficiently to 
survive outside of the womb. Early detection and the development of effective treatment 
regimens requires an understanding of the etiology of the disease.
A number of previous studies have shown a statistical correlation between micronutrient 
levels in the mother and the occurrence of preeclampsia.[28] Zinc is an essential trace 
micronutrient that plays a role in signaling proteins and catalytic enzymes, and its deficiency 
has been linked to a wide variety of adverse health outcomes.[29] Maternal plasma zinc 
concentrations have been found to naturally decrease during pregnancy, and some studies 
have found that individuals suffering from preeclampsia exhibit zinc levels that are 
decreased relative to normal pregnancies, with lower levels observed in more severe cases.
[30–32] One study demonstrated a correlation between decreased zinc absorption and iron 
and folic acid dietary supplements that are commonly prescribed to pregnant women.[33] 
Maternal serum levels of other elements, including copper, zinc, and iron were shown to be 
lower in preeclamptic women than in normal pregnant women.[34] The ability to mitigate 
the occurrence of preeclampsia through the administration of dietary mineral supplements is 
a subject of some debate.[18,35] Other studies have shown that administration of 
multivitamins containing essential micronutrients preconception can result in a significant 
decrease in the rate of occurrence of preeclampsia and other adverse birth outcomes.[36] An 
appropriate analytical method that provides consistent concentrations of zinc and other 
micronutrients could shed some light on the etiology of the disease, providing novel 
strategies for preventing the development of the disease.
However, beyond the study of preeclampsia, there are a variety of other conditions and 
health outcomes that can be studied with the broad panel approach validated here.[37] Low 
maternal iron levels have been suggested to influence birth weight, and iron and folic acid 
supplementation has previously been correlated to low maternal zinc uptake.[35] Prenatal 
iron deficiency has also been linked to neurocognitive developmental effects in early 
childhood.[38] Vitamin B12 (cobalamin, a cobalt compound) deficiencies in maternal diets 
have been linked to low fetal growth and other adverse symptoms including cleft palate.[39] 
Nutritional deficiencies are very frequently observed in developing countries, making 
dietary uptake and maternal health an urgent health equity issue.[40]
Additionally, exposures to toxic metals may be of greater concern in developing countries as 
a result of less stringent controls on environmental release, less developed testing and 
treatment systems, and the availability of consumer products containing toxic metals.[41] 
Maternal occupational exposure to nickel has been found to be linked to the development of 
musculoskeletal birth defects.[38] Elevated lead levels are observed in children in 
developing countries, which can have a strongly adverse effect on neurocognitive 
development.[42] Arsenic exposure from the water supply has been observed in some 
eastern Asian countries including Bangladesh, which can result in neurocognitive effects 
and other health outcomes.[43]
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Conclusions
The analysis of biological tissues for trace metals can provide invaluable information 
regarding the etiology of diseases and other outcomes, as well as providing an assessment of 
environmental exposure to contaminants that may be correlated to adverse health outcomes 
later in life. The accurate determination of the levels of trace elements requires a robust 
sample preparation and analysis method that provides reliable, precise results. The method 
of sample homogenization and acid digestion detailed in this report has been validated for 
inter- and intraday accuracy and precision and matrix effects on the analytical signal and has 
demonstrated a high degree of reproducibility of results. The results suggest that the method 
can provide strong analytical results in support of studies to assess maternal and natal health 
and their relationship to the environmental exposome.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
A flow diagram showing the sample preparation method developed and validated here.
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Table 1
Instrumental parameters for the ICP-MS analysis of digested placenta samples
Instrument Thermo X Series I ICP-MS
Software PlasmaLab ICP-MS Software, Version 2.3.0.161
Nebulizer Type Glass Concentric
Spray Chamber Peltier cooled
Collision Cell Gas 10% H2/He
Injector 1.8 mm
Analyte Masses 52Cr, 56Fe, 59Co, 60Ni, 63Cu, 66Zn, 75As, 111Cd, 208Pb
Internal Standard Masses 89Y, 115In, 141Pr, 209Bi
Cones Ni HPI
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Table 4
Analytical figures of merit
Analyte LLOQa (μg/g) ULOQb (μg/g) LODc (μg/g)
As 0.00855 0.427 0.001
Cd 0.00214 0.427 0.001
Co 0.00427 0.427 0.0007
Cr 0.00855 0.427 0.005
Cu 0.427 8.55 0.04
Fe 21.4 214 8
Ni 0.0855 8.55 0.04
Pb 0.00427 0.427 0.0009
Zn 4.27 42.7 1
a
Lower limit of quantitation (LLOQ) defined as lowest matrix QC level with %RE within ±15% and %RSD ≤20% on all three validation days.
bUpper limit of quantitation (ULOQ) defined as highest matrix standard included in regression.
c
Limit of detection (LOD) calculated as three times the standard deviation of determined concentrations for matrix QC replicates (n = 3 or 6) on 
the first validation day.
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Table 5
Dilution verification
Analyte RE (%) RSD (%)
As 1 0.40
Cd 1 1.4
Co −3 0.96
Cr −7 0.75
Cu 10 1.2
Fe −1 4.0
Ni −1 0.17
Pb 2 0.36
Zn 11 0.6
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